genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Gene Therapy
Bayer Approach to Partnerships, Pipelines, and Platforms
Genomics
Genomics in the Clinic: A Candid Conversation with Sema4 CEO Eric…
Circulating Tumor Cell
Illumina Launching Pan-Cancer IVD Test, Cloud-Based Bioinformatics Platform
Biomarkers
Guardant Health Launches Early-Stage Colorectal Cancer ctDNA Assay
GEN Edge
EY Firepower Report: Biopharma M&A Poised to Rebound in 2021
News
CRISPR-Cas9
Natural CRISPR’s Safety Feature Could Become Genetic Dimmer Switch
Antibodies
Lilly, Merus Ink Up-to-$1.6B Bispecific Antibody Partnership vs. Cancer
Infectious Diseases
Taurine Enhances the Microbiome’s Resistance to Future Pathogens
Genome Editing
DARPA to Fund CRISPR Diagnostics Using Mammoth, IDbyDNA Technologies
Gene Therapy
Paralyzed Mice Walk Again after Treatment with Designer Cytokine
Insights
All
Trends for 2021
Trends for 2020
Bioprocessing
Biopharma Manufacturers Shouldn’t Rush When “Going Digital”
Bioprocessing
Separating Cells with Microfluidics
Trends for 2021
Beyond 2021: Cell Therapy Manufacturing Trends
Bioprocessing
Machine Learning for Better Bioprocess Data Analysis
A-Lists
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
CRISPR-Cas9
Natural CRISPR’s Safety Feature Could Become Genetic Dimmer Switch
Bioprocessing
Biopharma Manufacturers Shouldn’t Rush When “Going Digital”
Bioprocessing
Separating Cells with Microfluidics
Trends for 2021
Beyond 2021: Cell Therapy Manufacturing Trends
Magazine
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
January 2021 Vol. 41 No. 1
Leroy Hood: Reflections on a Legendary Career
January 2021 Vol. 41 No. 1
COVID-19 One Year Later: The Biology and the Business
Traditional Medicine
Monoclonal Antibodies: Developers Explore New Territories
Roundtable
Uncharted Territory: Top Challenges Facing Gene Therapy Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Drug Discovery
Target Identification
Target Identification
7 days popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Target Identification
Cannabis Combo Therapy Triples Pancreatic Cancer Survival Rate
Target Identification
CRISPR Human Knockout Screens Identify New Target for ALS
Target Identification
Newly Uncovered Pathway Points to New Strategies Against Ovarian Cancer
Target Identification
UCB Acquires Element Genomics, with Targeted Therapies in Mind
Target Identification
Noncoding RNA Drug Target for Colon Cancer Discovered
Target Identification
Testicular Cancer Mapped Genomically and Epigenomically
Target Identification
New Prostate Cancer Subtype Identified, Responsive to Immunotherapy
Target Identification
Aggressive Brain Cancer Can Be Driven by Tumor Suppressor
Target Identification
Prostate Cancer Treatment Response Activated by Skin Disease Immunotherapy
Target Identification
Exercise Pathway That Regulates Muscle Remodeling May Have Implications for Metabolic...
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Depiction of the molecular processes involved in a new subtype of metastatic prostate cancer characterized by loss of the gene CDK12. [Alexander Tokarev/Ella Maru Studio]](https://www.genengnews.com/wp-content/uploads/2018/08/Jun14_2018__AlexanderTokarev_CDK121791251469-324x160.jpg "New Prostate Cancer Subtype Identified, Responsive to Immunotherapy")
![Treated prostate cancer cells. [Mateus Crespo/Professor Johann de Bono/ICR]](https://www.genengnews.com/wp-content/uploads/2018/08/Jun28_2018_ProfJohannDeBonoICR_TreatedProstateCancerCells1561322408-324x160.jpg "Prostate Cancer Treatment Response Activated by Skin Disease Immunotherapy")
